Rosiglitazone accelerates wound healing by improving endothelial precursor cell function and angiogenesis in db/db mice

Rosiglitazone accelerates wound healing by improving endothelial precursor cell function and angiogenesis in db/db mice

Background & Aims Endothelial precursor cell (EPC) dysfunction is one of the risk factors for diabetes mellitus (DM) which results in delayed wound healing. Rosiglitazone (RSG) is a frequently prescribed oral glucose-lowering drug. Previous studies have shown the positive effects of RSG on ameli...

Full description

Bibliographic Details
Main Authors: Guoliang Zhou, Xue Han, Zhiheng Wu, Qiaojuan Shi, Xiaogang Bao
Format: Article
Language:English
Published: PeerJ Inc. 2019-10-01
Series:PeerJ
Subjects:
Diabetes mellitus
Rosiglitazone
Endothelial precursor cell
Angiogenesis
Wound healing
Vascular endothelial growth factor
Online Access:https://peerj.com/articles/7815.pdf

Internet

https://peerj.com/articles/7815.pdf

Similar Items